What the FDA labels say about taking them together
Telavancin and vancomycin
Telavancin's FDA label of December 19, 2025 names vancomycin in its warnings and precautions section; the vancomycin labels PlainMeds reads (4) do not name telavancin.
Check it at the source: the telavancin FDA label on DailyMed (effective December 19, 2025, Cumberland Pharmaceuticals Inc.); the vancomycin FDA label on DailyMed (effective June 7, 2024, Mylan Institutional LLC).
What does the telavancin label say about vancomycin?
Telavancin label, warnings and precautionsVIBATIV should be used with caution in patients with known hypersensitivity to vancomycin. ( 5.6 , 6.2 ) Infusion-related reactions:
Source: FDA drug label (VIBATIV), NDA022110 (Apotex), as published by Cumberland Pharmaceuticals Inc., effective December 19, 2025 (SPL set 5359b759-db7c-4672-9e8a-59c93869bd91), via openFDA; the full label on DailyMed
What does the vancomycin label say about telavancin?
Vancomycin's label (effective June 7, 2024) and its 3 other brand-application labels do not name telavancin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Vancomycin Hydrochloride), Mylan Institutional LLC, effective June 7, 2024 (SPL set caf22ccb-df75-45ea-a1d0-ccb2d37272fb), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Telavancin | Vancomycin | |
|---|---|---|
| Labeled for | n/a | Bacterial infections, Diarrhea |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | n/a | $1.33 per capsule 125 mg capsule |
| Shortage now | No current entry | A presentation being discontinued |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once